PROCEPT BioRobotics Corporation Common Stock (PRCT) is a publicly traded Healthcare sector company. As of July 14, 2026, PRCT trades at $19.42 with a market cap of $1.21B and a P/E ratio of -11.08. PRCT moved -9.02% today. Year to date, PRCT is -38.62%; over the trailing twelve months it is -66.80%. Its 52-week range spans $18.67 to $100.89. Analyst consensus is buy with an average price target of $29.38. Rallies surfaces PRCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for PRCT combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $19.42 |
| Market Cap | $1.21B |
| P/E Ratio | -11.08 |
| EPS | $-1.72 |
| Dividend Yield | 0.00% |
| 52-Week High | $100.89 |
| 52-Week Low | $18.67 |
| Volume | 1.63M |
| Avg Volume | 0 |
| Revenue (TTM) | $308.05M |
| Net Income | $-95.57M |
| Gross Margin | 63.70% |
10 analysts cover PRCT: 0 strong buy, 5 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $29.38.